RAF1
RAF1 (Raf-1 proto-oncogene, serine/threonine kinase; also known as c-Raf and CRAF) is a MAP kinase kinase kinase that links membrane-associated Ras GTPases to the MAPK/ERK cascade. Through this link it influences cell fate decisions, including proliferation, differentiation, apoptosis and survival. Browse Assay Genie's current range of RAF1 research reagents below, or read on for the biology behind the target.
RAF1 is a serine/threonine-protein kinase that acts as a regulatory link between membrane-associated Ras GTPases and the MAPK/ERK cascade. This link works as a switch for cell fate decisions, including proliferation, differentiation, apoptosis, survival and oncogenic transformation. Once activated, RAF1 phosphorylates the dual-specificity kinases MEK1 and MEK2 (MAP2K1 and MAP2K2), which in turn phosphorylate ERK1 and ERK2 (MAPK3 and MAPK1). Activated ERKs are pleiotropic effectors that control gene expression involved in the cell division cycle, apoptosis, cell differentiation and cell migration.
Beyond the core cascade, RAF1 phosphorylated on Ser-338 and Ser-339 by PAK1 phosphorylates BAD at Ser-75. RAF1 also phosphorylates the adenylyl cyclases ADCY2, ADCY5 and ADCY6, activating them, and phosphorylates PPP1R12A, inhibiting its phosphatase activity. It can promote NF-kB activation and inhibit ROCK2, MAP3K5 (ASK1), STK3 (MST2) and RB1. By translocating to mitochondria, where it binds BCL2 and displaces BAD, RAF1 can protect cells from apoptosis. It also regulates Rho signalling and migration, and is required for normal wound healing.
The RAF1 gene is the cellular homologue of the viral raf gene (v-raf), and its earlier name was v-raf-1 murine leukaemia viral oncogene homolog 1. The protein belongs to the RAF subfamily of the TKL Ser/Thr protein kinase family. UniProt reports it in the cytoplasm, cell membrane, mitochondrion and nucleus. RAF1 contributes to oncogenic transformation of epithelial cells by driving SNAI2/SLUG up-regulation and consequent repression of occludin. Mutations in the gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2.
RAF1 sits downstream of Ras and upstream of MEK1/2 and ERK1/2, making it central to studies of this cascade.
RAF1 is a proto-oncogene, and contributes to oncogenic transformation, including epithelial transformation through SNAI2/SLUG-mediated repression of occludin.
RAF1 phosphorylates BAD, binds BCL2 at mitochondria and restricts caspase activation, so it is relevant to cell survival research.
Mutations in RAF1 are associated with Noonan syndrome 5 and LEOPARD syndrome 2, linking the kinase to developmental disease studies.
RAF1 is a serine/threonine kinase that connects Ras GTPases to the MAPK/ERK cascade. When activated, it phosphorylates MEK1 and MEK2, which activate ERK1 and ERK2. This pathway controls proliferation, differentiation, apoptosis, survival and migration. RAF1 also has roles at mitochondria, where it can protect cells from apoptosis.
RAF1 is also called Raf-1, c-Raf and CRAF. Its earlier gene name was v-raf-1 murine leukaemia viral oncogene homolog 1, reflecting its status as the cellular homologue of the viral raf gene (v-raf). HGNC places it in the RAF family of MAP kinase kinase kinases.
Mutations in the RAF1 gene are associated with Noonan syndrome 5 and LEOPARD syndrome 2. Orthologues exist in mouse and rat, both named Raf1. Check the datasheet of any product for its validated reactivity.
Other MAPK cascade components, apoptosis regulators and RAF1 substrates and partners relevant to Ras/ERK signalling research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04049; product specifications from Assay Genie datasheets.